Rivinius Rasmus, Helmschrott Matthias, Rahm Ann-Kathrin, Darche Fabrice F, Thomas Dierk, Bruckner Tom, Doesch Andreas O, Ehlermann Philipp, Katus Hugo A, Zitron Edgar
Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Heidelberg Center for Heart Rhythm Disorders (HCR), Heidelberg University Hospital, Heidelberg, Germany.
J Thorac Dis. 2019 Dec;11(12):5440-5452. doi: 10.21037/jtd.2019.11.45.
Permanent pacemaker (PPM) implantation after heart transplantation (HTX) may be required due to severe bradycardia. The aim of this study was to investigate the risk factors, indications, perioperative outcomes and complications of PPM implantation after HTX as well as the underlying effect on post-transplant mortality including causes of death.
This registry study included 621 patients receiving HTX at Heidelberg Heart Center between 1989 and 2018. Patients were stratified by PPM implantation after HTX. Data analysis of risk factors for PPM implantation included donor and recipient demographics, post-transplant medication, mortality, and causes of death.
Thirty-six patients (5.8%) received PPM implantation after HTX, 12 (33.3%) with early PPM and 24 (66.7%) with late PPM. Indications for PPM implantation after HTX included sinus node dysfunction (SND) (n=15; 41.7%) and atrioventricular block (AVB) (n=21; 58.3%). Multivariate analysis revealed recipient body mass index (BMI) [hazard ratio (HR): 1.10; confidence interval (CI): 1.01-1.21; P=0.03], donor age (HR: 1.07; CI: 1.03-1.10; P<0.01), and biatrial HTX (HR: 2.63; CI: 1.22-5.68; P=0.01) as significant risk factors for PPM implantation after HTX. Kaplan-Meier estimator displayed a statistically significant inferior 5-year post-transplant survival among patients with early PPM after HTX in comparison to patients with late PPM or no PPM after HTX (P<0.01) along with a higher percentage of death due to infection (P<0.01).
Multivariate risk factors for PPM implantation after HTX include recipient BMI, donor age, and biatrial HTX. Early PPM implantation after HTX is associated with increased 5-year post-transplant mortality due to infection.
心脏移植(HTX)后因严重心动过缓可能需要植入永久性起搏器(PPM)。本研究旨在调查HTX后PPM植入的危险因素、适应证、围手术期结局及并发症,以及对移植后死亡率的潜在影响,包括死亡原因。
这项登记研究纳入了1989年至2018年在海德堡心脏中心接受HTX的621例患者。患者按HTX后是否植入PPM进行分层。PPM植入危险因素的数据分析包括供体和受体的人口统计学特征、移植后用药、死亡率及死亡原因。
36例患者(5.8%)在HTX后接受了PPM植入,其中12例(33.3%)为早期PPM,24例(66.7%)为晚期PPM。HTX后PPM植入的适应证包括窦房结功能障碍(SND)(n = 15;41.7%)和房室传导阻滞(AVB)(n = 21;58.3%)。多因素分析显示,受体体重指数(BMI)[风险比(HR):1.10;置信区间(CI):1.01 - 1.21;P = 0.03]、供体年龄(HR:1.07;CI:1.03 - 1.10;P < 0.01)和双房HTX(HR:2.63;CI:1.22 - 5.68;P = 0.01)是HTX后PPM植入的重要危险因素。Kaplan - Meier估计显示,HTX后早期植入PPM的患者与晚期植入PPM或未植入PPM的患者相比,移植后5年生存率在统计学上显著较低(P < 0.01),且因感染死亡的比例更高(P < 0.01)。
HTX后PPM植入的多因素危险因素包括受体BMI、供体年龄和双房HTX。HTX后早期植入PPM与移植后5年因感染导致的死亡率增加相关。